Valuein

Overview

AMPHENOL CORP /DE/

APHNYSEInformation TechnologyElectronic ConnectorsCIK 0000820313Large-cap benchmark

Latest 10-K: FY2025, filed Feb 11, 2026 · Open the 10-K (Inline XBRL) ↗

Revenue
$23.09B
51.7%YoYup from FY2024
TotalRevenue
Gross profit
$8.52B
65.7%YoYup from FY2024
GrossProfit
Operating income
$5.87B
85.9%YoYup from FY2024
OperatingIncome
Net income
$4.27B
76.2%YoYup from FY2024
NetIncome
Diluted EPS
$3.34
74.0%YoYup from FY2024
EPSDiluted
Diluted shares
1.28B
1.1%YoYup from FY2024
WeightedAvgSharesDiluted

At a glance

Growth

  • AMPHENOL CORP /DE/ reported revenue of $23.09B for fiscal 2025, up 51.7% from fiscal 2024.
  • Revenue grew faster than the median S&P 500 member in 4 of the last 5 fiscal years.

Profitability

  • Operating margin was 25.4% and net margin was 18.5%, against a median net margin of 12.8% across S&P 500 members for the same fiscal year.

Per share

  • Diluted EPS was $3.34, up 74.0% from the prior year.
Loading insider and institutional summary

Written from the filed figures on this page by fixed rules — no AI.

Data as of Oct 31, 2026 · Sources: SEC EDGAR 10-K

Financial statements

Annual figures from the 10-K, most recent fiscal year first.

Income Statement

5 annual periods

Chip: YoY change.

Income Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Revenue
$23.09B51.7%up
Benchmark median 6.4%
$15.22B21.3%up
Benchmark median 4.5%
$12.55B0.5%down
Benchmark median 4.8%
$12.62B16.1%up
Benchmark median 10.3%
$10.88B26.5%up
Benchmark median 13.8%
20.7%
Benchmark median 6.6%
Gross Profit
Median of 315 / 498
$8.52B65.7%up
Benchmark median 6.8%
$5.14B25.8%up
Benchmark median 5.5%
$4.08B1.4%up
Benchmark median 5.2%
$4.03B18.4%up
Benchmark median 8.3%
$3.40B27.7%up
Benchmark median 15.7%
25.8%
Benchmark median 6.2%
Operating Income
Median of 373 / 498
$5.87B85.9%up
Benchmark median 7.3%
$3.16B23.3%up
Benchmark median 7.4%
$2.56B1.0%down
Benchmark median 4.9%
$2.59B22.8%up
Benchmark median 7.5%
$2.11B28.5%up
Benchmark median 23.5%
29.2%
Benchmark median 7.2%
Net Income
$4.27B76.2%up
Benchmark median 4.8%
$2.42B25.7%up
Benchmark median 5.7%
$1.93B1.4%up
Benchmark median 1.9%
$1.90B19.6%up
Benchmark median 1.3%
$1.59B32.2%up
Benchmark median 33.9%
28.0%
Benchmark median 4.1%
EPS (Diluted)
$3.3474.0%up
Benchmark median 6.2%
$1.9223.9%up
Benchmark median 7.9%
$1.551.3%up
Benchmark median 1.9%
$1.53‡n/m
Benchmark median 1.5%
$2.5429.6%up
Benchmark median 34.8%
n/m
Benchmark median 5.6%

‡ Share basis changed between these years (stock split or reverse split).

Balance Sheet

5 annual periods

Chip: YoY change.

Balance Sheet, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Total Assets
$36.24B69.0%up
Benchmark median 5.6%
$21.44B29.7%up
Benchmark median 3.4%
$16.53B7.8%up
Benchmark median 4.1%
$15.33B4.4%up
Benchmark median 2.2%
$14.68B19.1%up
Benchmark median 6.7%
25.3%
Benchmark median 4.7%
Total Liabilities
Median of 357 / 498
$22.73B96.2%up
Benchmark median 6.4%
$11.58B43.0%up
Benchmark median 1.9%
$8.10B1.6%down
Benchmark median 2.9%
$8.23B0.8%down
Benchmark median 2.0%
$8.30B20.7%up
Benchmark median 5.2%
28.6%
Benchmark median 4.4%
Stockholders' Equity
$13.50B37.1%up
Benchmark median 6.8%
$9.85B17.3%up
Benchmark median 5.4%
$8.40B18.7%up
Benchmark median 7.3%
$7.07B11.2%up
Benchmark median 2.5%
$6.36B16.7%up
Benchmark median 9.0%
20.7%
Benchmark median 6.1%
Cash & Equivalents
$11.13B235.6%up
Benchmark median 5.2%
$3.32B124.9%up
Benchmark median 1.9%
$1.48B7.4%up
Benchmark median 6.7%
$1.37B14.7%up
Benchmark median -8.6%
$1.20B29.7%down
Benchmark median -2.9%
74.6%
Benchmark median 2.0%
Total Debt
$15.50B125.1%up
Benchmark median 2.1%
$6.89B58.8%up
Benchmark median 0.2%
$4.34B5.3%down
Benchmark median 0.3%
$4.58B4.6%down
Benchmark median 0.1%
$4.80B24.1%up
Benchmark median -0.1%
34.1%
Benchmark median 4.3%

Cash Flow Statement

5 annual periods

Chip: YoY change.

Cash Flow Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Operating Cash Flow
$5.37B91.0%up
Benchmark median 6.3%
$2.81B11.3%up
Benchmark median 4.8%
$2.53B16.3%up
Benchmark median 9.9%
$2.17B41.2%up
Benchmark median -0.7%
$1.54B3.3%down
Benchmark median 10.7%
36.7%
Benchmark median 7.0%
Capital Expenditures
$996.60M49.8%up
Benchmark median 5.4%
$665.40M78.5%up
Benchmark median 2.8%
$372.80M2.9%down
Benchmark median 11.3%
$383.80M6.5%up
Benchmark median 14.0%
$360.40M30.2%up
Benchmark median 8.1%
29.0%
Benchmark median 9.0%
Free Cash Flow
Median of 378 / 498
$4.38B103.7%up
Benchmark median 7.3%
$2.15B0.3%down
Benchmark median 6.1%
$2.16B20.4%up
Benchmark median 8.8%
$1.79B51.8%up
Benchmark median -11.3%
$1.18B10.3%down
Benchmark median 10.2%
38.8%
Benchmark median 4.9%

n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.

Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology

Ratios & valuation

FY2025

Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.

Valuation · Earnings yield

What a dollar of market value earned

2.5%

Wall Street

on net earnings

FY2024 2.8%

2.5%

Value investor

on free cash flow

FY2024 2.4%

Gap Same: Both views read the same

How it’s calculated

Wall Street · on net earnings

Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)

pe_ratio (ratio table)

P/E 40.5×

Value investor · on free cash flow

(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)

free cash flow ÷ market cap

Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.

Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.

Loading capital allocation

Smart money

Loading insider and institutional activity

Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.

Peers, filings & research

Loading sector peers
Loading recent filings

Research Reports

No published research on APH yet.

Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on APH and publish the result to your public profile.

Loading the data behind this page

Cite this page

Data as of Oct 31, 2026. Canonical address: https://valuein.biz/data/APH

APA-style text
Valuein. (2026, October 31). AMPHENOL CORP /DE/ (APH) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/APH
BibTeX
@misc{valuein_aph_2026,
  author = {{Valuein}},
  title = {AMPHENOL CORP /DE/ (APH) financial statements, earnings power and smart-money summary},
  year = {2026},
  howpublished = {\url{https://valuein.biz/data/APH}},
  note = {Data as of 2026-10-31; source: SEC EDGAR filings}
}
Open 10-K in SEC Inline XBRL viewer

10-K filed Feb 11, 2026 · accession 0001104659-26-013549

Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.

point-in-time · survivorship-free · every number traceable to its SEC filing

Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.